Corteva lifts outlook, but investors want more than margin growth ahead of split

Corteva Agriscience raised its full-year earnings outlook after strong first-half results driven by premium seed technologies, licensing growth, and operational discipline, but shares declined as investors focused on weaker-than-expected revenue and questioned the sustainability of profit growth ahead of the company's planned October split. While the seed business delivered robust organic growth and crop protection remained profitable, ongoing pricing pressures—especially in Brazil—persist. Management highlighted innovation in seed genetics, crop protection, and biologicals as strategic strengths, yet investors seek clearer evidence that these initiatives can translate into sustained top-line growth beyond margin expansion. The upcoming separation into two standalone companies remains on track, with future growth and earnings momentum drawing heightened investor scrutiny.